Open access · CC-BY
via OpenAlex
Safety evaluation after acute and sub-chronic oral administration of high purity nicotinamide mononucleotide (NMN-C®) in Sprague-Dawley rats
Cécile D. Cros, Hélène Cannelle, Laurent Laganier, Alessia Grozio, Matthias Canault
Food and Chemical Toxicology · 2021 · ▲ 23 citations
Abstract
). Preclinical evidences point to the beneficial effect of NMN administration on several age-related conditions. The present work aimed at studying mutagenicity, and genotoxicity, acute oral toxicity and subchronic oral toxicity of a high purity synthetic form of NMN (NMN-C®) following the OECD guidelines. In the experimental conditions tested, NMN-C® was not mutagenic or genotoxic. Acute toxicity assay revealed that at an oral limit dose of 2666 mg/kg, NMN-C® did not lead to any mortality or treatment-related adverse signs. Over a 90-day sub-chronic period of repeated oral administration of NMN-C® at doses of 375, 750 and 1500 mg/kg/d followed by a 28-day treatment-free recovery period, NMN-C® appeared to be safe and did not promote toxic effects as seen from body weight change, food and water consumption, feed conversion efficiency, biochemical and blood parameters as well as organ toxicity and histological examinations of main organs. In conclusion, we provide the first data highlighting the safety of short to intermediate term (sub-chronic) oral administration of NMN and our experimental results allowed to determine a No-Observable Adverse Effect Level (NOAEL) for NMN-C® to be ≥ 1500 mg/kg/d.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.fct.2021.112060
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Cros, C.D., Cannelle, H., Laganier, L., Grozio, A., & Canault, M. (2021). Safety evaluation after acute and sub-chronic oral administration of high purity nicotinamide mononucleotide (NMN-C®) in Sprague-Dawley rats. <em>Food and Chemical Toxicology</em>. https://doi.org/10.1016/j.fct.2021.112060
Vancouver
Cros CD, Cannelle H, Laganier L, Grozio A, Canault M. Safety evaluation after acute and sub-chronic oral administration of high purity nicotinamide mononucleotide (NMN-C®) in Sprague-Dawley rats. Food and Chemical Toxicology. 2021. doi:10.1016/j.fct.2021.112060.
BibTeX
@article{ccile2021Safety,
title = {Safety evaluation after acute and sub-chronic oral administration of high purity nicotinamide mononucleotide (NMN-C®) in Sprague-Dawley rats},
author = {Cécile D. Cros and Hélène Cannelle and Laurent Laganier and Alessia Grozio and Matthias Canault},
journal = {Food and Chemical Toxicology},
year = {2021},
doi = {10.1016/j.fct.2021.112060},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Aging 2026
Open access · CC-BY
Longitudinal changes in epigenetic clocks predict survival in the InCHIANTI cohort
Scientific reports 2026
Open access · OA
Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men.
American Journal of Psychiatry 2018
Open access · OA
Analysis of DNA Methylation in Young People: Limited Evidence for an Association Between Victimization Stress and Epigenetic Variation in Blood
Obesity Reviews 2007
Citation only
Report on the IASO Stock Conference 2006: early and lifelong environmental epigenomic programming of metabolic syndrome, obesity and type II diabetes
Frontiers in Nutrition 2022
Open access · CC-BY
Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects
University of California, San Francisco 2013
Open access · US-GOV